BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
phaarmasia ltd. stock

PHAARMASIA LTD. Share Price

45.76 -4.14 (-8.29%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: PHRMASI

PHAARMASIA LTD. Share Price Update

As of the latest trading session, PHAARMASIA LTD. share price is currently at 45.76, which is down by -4.14 from its previous closing. Today, the stock has fluctuated between 45.55 and 49.90. Over the past year, PHAARMASIA LTD. has achieved a return of 72.67 %. In the last month alone, the return has been -0.49 %. Read More...

PHAARMASIA LTD. Performance

Day Range

Low45.55 High49.90
45.88

52 Week Range

Low 25.75 High 64.75
45.88

PHAARMASIA LTD. Share Price

523620

PHRMASI

img img img img
No Data Available

Open Price

49.90

Prev. Close

49.90

Volume (Shares)

279.00

Total traded value

.13

Upper Circuit

54.89

Lower Circuit

44.91

Note: The current prices & values are delayed, Login to your account for live updates.

PHAARMASIA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 31.30
PE Ratio (TTM) -68.48
Book Value / Share 8.33
Beta 0.53
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.64

PHAARMASIA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 5.93
Operating Expense 6.79
Net Profit -0.64
Net Profit Margin (%) -10.79
Earnings Per Share (EPS) -0.94
EBITDA -0.57
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 8.29
Operating Expense 8.19
Net Profit 0.28
Net Profit Margin (%) 3.37
Earnings Per Share (EPS) 0.40
EBITDA 0.33
Effective Tax Rate (%) -12.00
Particulars MAR 2024 (Values in Cr)
Revenue 9.99
Operating Expense 9.74
Net Profit 0.47
Net Profit Margin (%) 4.70
Earnings Per Share (EPS) 0.69
EBITDA 0.53
Effective Tax Rate (%) -9.09
Particulars DEC 2023 (Values in Cr)
Revenue 5.08
Operating Expense 5.75
Net Profit -0.56
Net Profit Margin (%) -11.02
Earnings Per Share (EPS) -0.83
EBITDA -0.44
Effective Tax Rate (%) -3.70
Particulars SEP 2023 (Values in Cr)
Revenue 8.64
Operating Expense 9.02
Net Profit -0.16
Net Profit Margin (%) -1.85
Earnings Per Share (EPS) -0.24
EBITDA -0.07
Effective Tax Rate (%) 5.88
Particulars MAR 2024 (Values in Cr)
Revenue 30.59
Operating Expense 31.80
Net Profit -0.52
Net Profit Margin (%) -1.69
Earnings Per Share (EPS) -0.76
EBITDA -0.16
Effective Tax Rate (%) 5.45
Particulars MAR 2023 (Values in Cr)
Revenue 27.49
Operating Expense 29.43
Net Profit -1.26
Net Profit Margin (%) -4.58
Earnings Per Share (EPS) -1.84
EBITDA -1.02
Effective Tax Rate (%) 11.88
Particulars MAR 2022 (Values in Cr)
Revenue 17.22
Operating Expense 19.24
Net Profit -1.55
Net Profit Margin (%) -9.00
Earnings Per Share (EPS) -2.27
EBITDA -1.27
Effective Tax Rate (%) 1.28
Particulars MAR 2021 (Values in Cr)
Revenue 19.90
Operating Expense 20.31
Net Profit 0.31
Net Profit Margin (%) 1.55
Earnings Per Share (EPS) 0.46
EBITDA 0.83
Effective Tax Rate (%) 35.41
Particulars MAR 2020 (Values in Cr)
Revenue 24.45
Operating Expense 24.07
Net Profit 0.54
Net Profit Margin (%) 2.20
Earnings Per Share (EPS) 0.79
EBITDA 1.40
Effective Tax Rate (%) 43.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 8.87
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.03
EBITDA Margin -0.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.62
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -3.75
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.45
ROE % -17.98
ROCE % -17.75
Total Debt to Total Equity 0.00
EBITDA Margin -7.38
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.79
ROE % 3.34
ROCE % 5.02
Total Debt to Total Equity 0.01
EBITDA Margin 5.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.43
ROE % 6.08
ROCE % 10.43
Total Debt to Total Equity 0.02
EBITDA Margin 7.02
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.63
Total Assets 31.44
Total Liabilities 31.44
Total Equity 10.29
Share Outstanding 6826960
Price to Book Ratio 3.28
Return on Assets (%) -1.64
Return on Capital (%) -5.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.69
Total Assets 28.42
Total Liabilities 28.42
Total Equity 10.80
Share Outstanding 6827000
Price to Book Ratio 2.43
Return on Assets (%) -4.43
Return on Capital (%) -11.64
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 21.20
Total Liabilities 21.20
Total Equity 12.05
Share Outstanding 6827000
Price to Book Ratio 2.70
Return on Assets (%) -7.29
Return on Capital (%) -12.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.38
Total Assets 21.91
Total Liabilities 21.91
Total Equity 13.65
Share Outstanding 6826960
Price to Book Ratio 1.80
Return on Assets (%) 1.42
Return on Capital (%) 2.28
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 33.59
Total Liabilities 33.59
Total Equity 13.40
Share Outstanding 6826960
Price to Book Ratio 1.04
Return on Assets (%) 1.60
Return on Capital (%) 4
Particulars MAR 2024 (Values in Cr)
Net Income -0.54
Cash from Operations 0.10
Cash from Investing 0.00
Cash from Financing -0.16
Net change in Cash -0.05
Free Cash Flow 0.13
Particulars MAR 2023 (Values in Cr)
Net Income -1.43
Cash from Operations 0.64
Cash from Investing -0.01
Cash from Financing -0.16
Net change in Cash 0.47
Free Cash Flow 0.67
Particulars MAR 2022 (Values in Cr)
Net Income -1.56
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.16
Free Cash Flow 0.00
Particulars MAR 2021 (Values in Cr)
Net Income 0.47
Cash from Operations 0.49
Cash from Investing 0.00
Cash from Financing -0.02
Net change in Cash 0.22
Free Cash Flow 0.49
Particulars MAR 2020 (Values in Cr)
Net Income 0.96
Cash from Operations 0.33
Cash from Investing 0.00
Cash from Financing -0.11
Net change in Cash -0.03
Free Cash Flow 0.33
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2254.45 47.63 22.83 38191.74 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 47.90
  • 26 Days 48.20
  • 10 Days 47.80
  • 50 Days 49.80
  • 12 Days 47.60
  • 100 Days 51.20
  • 20 Days 47.40
  • 200 Days 36.10
49.67
PIVOT
First Resistance 52.23
Second Resistance 54.56
Third Resistance 57.12
First Support 47.34
Second Support 44.78
Third Support 42.45
RSI 44.92
MACD -0.63
Commodity Channel Index (CCI) 5.06
ADX 12.50
Williams % R -72.68

Over 1 Month

down

-0.49

Over 3 Months

down

-28.90

Over 6 Months

down

7.44

Over 1 Year

down

72.67

Over 3 Years

down

15.53

Over 5 Years

down

17.14

PHAARMASIA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

PHAARMASIA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
26.42
Promoter Holdings
73.51
FII
0.0
DII
0.05
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Maneesh Pharmaceuticals Limited Shareholding of Promoter and Promoter Group 3018732.0 44.22
Svizera Labs Pvt Ltd Shareholding of Promoter and Promoter Group 2000000.0 29.3
Madhavi Pradeep Save Public Shareholding 118054.0 1.73
Amruta Nishant Kalsekar Public Shareholding 101512.0 1.49

PHAARMASIA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About PHAARMASIA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by PHAARMASIA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Phaarmasia Ltd?

Answer Field

The share price of Phaarmasia Ltd for NSE is ₹ 0.00 and for BSE is ₹ 45.88.

What is the Market Cap of Phaarmasia Ltd?

Answer Field

The market cap of Phaarmasia Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 31.30 Cr. as of now.

What is the 52 Week High and Low of Phaarmasia Ltd?

Answer Field

The 52 Week High and Low of Phaarmasia Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 64.75 and ₹ 25.75.

How to Buy Phaarmasia Ltd share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Phaarmasia Ltd?

Answer Field

The 1 year returns on the stock has been 72.67%.

What is the Current Share Price of Phaarmasia Ltd?

Answer Field

Phaarmasia Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 45.88 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Phaarmasia Ltd Share?

Answer Field

The market cap of Phaarmasia Ltd for NSE ₹ 0.0 & for BSE ₹ 31.30 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Phaarmasia Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Phaarmasia Ltd share is -68.48.

What is the PB ratio of Phaarmasia Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Phaarmasia Ltd share is 8.33.

How to Buy Phaarmasia Ltd Share?

Answer Field

You can trade in Phaarmasia Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Phaarmasia Ltd Share on Bajaj Broking App?

Answer Field

To buy Phaarmasia Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Phaarmasia Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader